Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05299580
Title Dabrafenib and Trametinib in Circulating Free DNA BRAFV600 Mutated Metastatic Melanoma Patients: a Prospective Phase II, Open Label, Multicentre Study - (Bioliquid TAILOR Study - BIOTAILOR)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Fondazione Melanoma Onlus
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Age Groups: adult | senior
Covered Countries ITA

Additional content available in CKB BOOST